How I Treat: Immune dysregulation in Down syndrome

Immune dysregulation is a clinically significant but often underrecognized feature of Down syndrome, with infection being the leading cause of mortality in this population due to underlying immunodeficiency and anatomical factors. Individuals with Down syndrome frequently experience autoimmune and autoinflammatory conditions affecting multiple organ systems, which present treatment challenges requiring specialized immunomodulatory approaches.